
Investing.com – Israel stocks were lower after the close on Monday, as losses in the Banking, Financials and Insurance sectors led shares lower.
At the close in Tel Aviv, the TA 35 lost 0.03%.
The best performers of the session on the TA 35 were Teva Pharmaceutical Industries Ltd (TASE:TEVA), which rose 2.82% or 117.00 points to trade at 4,269.00 at the close. Meanwhile, NICE Ltd (TASE:NICE) added 2.82% or 2,230.00 points to end at 81,290.00 and Tower Semiconductor Ltd (TASE:TSEM) was up 2.78% or 310.00 points to 11,480.00 in late trade.
The worst performers of the session were Newmed Energy LP (TASE:NWMDp), which fell 2.10% or 21.00 points to trade at 963.00 at the close. Electra Ltd (TASE:ELTR) declined 1.94% or 2,750.00 points to end at 139,030.00 and Mizrahi Tefahot (TASE:MZTF) was down 1.94% or 260.00 points to 13,140.00.
Falling stocks outnumbered advancing ones on the Tel Aviv Stock Exchange by 291 to 174 and 72 ended unchanged.
Crude oil for March delivery was up 1.56% or 1.14 to $74.39 a barrel. Elsewhere in commodities trading, Brent oil for delivery in March rose 1.34% or 1.05 to hit $79.61 a barrel, while the February Gold Futures contract fell 0.16% or 3.15 to trade at $2,026.15 a troy ounce.
USD/ILS was up 0.55% to 3.76, while EUR/ILS rose 0.46% to 4.10.
The US Dollar Index Futures was down 0.02% at 103.04.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.